Mainz Biomed Shares Are Trading Higher After the Company Announced the Submission for FDA Breakthrough Device Designation for Its CRC Screening Test
Mainz Biomed股票上涨,该公司宣布为其CRC筛查测试提交FDA突破性设备认定申请。
Mainz Biomed Shares Are Trading Higher After the Company Announced the Submission for FDA Breakthrough Device Designation for Its CRC Screening Test
Mainz Biomed Shares Are Trading Higher After the Company Announced the Submission for FDA Breakthrough Device Designation for Its CRC Screening Test
Mainz Biomed股票上涨,该公司宣布为其CRC筛查测试提交FDA突破性设备认定申请。
使用浏览器的分享功能,分享给你的好友吧